4 Studies found

Clostridium Difficile

Seeking adults 18 years or older who have had 3 or more infections with Clostridium difficile (CDI) in the past 9 months including at the time they join the study. Half of the participants will be given the study drug and the other half will be given a placebo (fake pill). You cannot choose and will not be told which group you are in while in the study.

18 or older

Compensation

Offered

Digestive and Liver Diseases

Seeking men and women with a clostridium difficile infection (CDI), also called C. Difficile or C. Diff, that has returned at least once for a study to see if an experimental drug is better than nothing in preventing additional episodes of CDI.

Gender

Male/Female

Age

Adult

Compensation

None

Digestive and Liver Diseases

Seeking people whose recurrent Clostridium difficile (C. diff) infection has not responded to standard antibiotic treatments for a study to see if fecal microbiota transplantation is effective for treating C. diff infection.

About

Support

Resources

The UMass Center for Clinical and Translational Science is part of the
Clinical and Translational Science Award (CTSA) program, funded by the
National Center for Advancing Translational Sciences (Grant #
UL1-TR001453) at the National Institutes of Health (NIH).
NIH Citation Requirements

This is an
official Page of
the University of Massachusetts Medical School